Atom Limbs

Sat Down with Chris Graebe at “The Crwd” 🎙️ + We Close This Week!

Published on Apr 8, 2024

Hi everyone,

As we wrap up the round this week, I wanted to quickly share an excellent chat I had with Chris Graebe.

For those who may not know, Chris is a distinguished investor and advisor, with a track record that includes investing alongside industry giants like Mark Cuban and Kevin O’Leary.

Following our recent feature at the top of his investor newsletter, "The Crwd," I had the opportunity to sit down with Chris for an in-depth discussion about how Atom Limbs is on the verge of disrupting the $800B physical disability industry.

As Chris put it:

"Atom Limbs is at the cutting edge of artificial limb technology.”

Topics we covered:

  • The Market. Atom is capitalizing on breakthroughs in robotics, AI, neural interfaces, and wearables to transform the tragically underserved $100M market for limb loss.
  • The Tech. Our state-of-the-art artificial arm aims to combine touch feedback, individual finger control, and all-day comfort. Demand is high — over 10,000 people have signed up for the waitlist, representing $200M+ in forecast revenue.
  • The Team. I’m joined by world-class cofounders Eric Monsef and Doug Satzger. Our team at Atom consists of industry leaders from Apple, Neuralink, and Baxter Healthcare.
  • Where we’re headed. We share our market debut timeline, including our path to clinical trials and FDA authorization, and new product features we can’t wait to get started on. 
  • Plus more updates you won’t want to miss! 

It was a real pleasure to sit down with Chris and to hear him share our enthusiasm for advanced prosthetics.

Watch the full conversation here 👀

Overall, it’s an exciting time here at Atom. We thank you once again for being part of our journey.

If you’d like to invest or increase your investment in Atom, we urge you to do so before we close →

If you’ve been meaning to share with friends / family / colleagues, act now before it’s too late!

Best,

Tyler

Liked by Zahid El Jemli, Dawn Pennington, Kenneth Leung, and 8 others